Stocksigma LogoStocksigma Logo

Saroja Pharma Industries Reports H1 Results for Period Ended 30th Sep'26

Saroja Pharma Industries India Limited approved its unaudited standalone financial results for the half-year ended 30th Sep'26

Saroja Pharma Industries Reports H1 Results for Period Ended 30th Sep'26

Saroja Pharma Industries India Ltd 路 Outcome 路 13 Nov 2026, 11:51 pm

Saroja Pharma Industries Reports H1 Results for Period Ended 30th Sep'26 Saroja Pharma Industries India Limited approved its unaudited standalone financial results for the half-year ended 30th Sep'26. Total income from operations declined to Rs 1,845.75 lakhs compared to Rs 3,876.41 lakhs in the corresponding period ended 30th Sep'25. Net profit for the period stood at Rs 52.82 lakhs versus Rs 56.98 lakhs YoY, while profit before tax was Rs 62.82 lakhs against Rs 78.28 lakhs YoY. Basic and diluted earnings per share came in at Rs 1.31 compared to Rs 1.42 reported in the prior-year period.

Original exchange filing (PDF)

More announcements from Saroja Pharma Industries India Ltd

All Saroja Pharma Industries India Ltd announcements